This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Other. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: The Innovations of Robert Edward Kearney
Introduction
Robert Edward Kearney is a notable inventor based in Montreal, Canada. He has made significant contributions to the field of diabetes management through his innovative patent. His work focuses on improving therapy parameters for diabetic subjects, showcasing his commitment to enhancing healthcare solutions.
Latest Patents
Kearney holds a patent for a "Method and system for determining optimal and recommended therapy parameters for diabetic subject." This patent outlines a comprehensive method for determining recommended multiple daily injections (MDI) therapy values for administering to a given subject. The system takes into account consumed meals, insulin basal doses, and insulin bolus doses administered to the subject. It predicts glucose concentration based on these factors and adjusts therapy parameters accordingly to optimize diabetes management.
Career Highlights
Throughout his career, Kearney has demonstrated a strong focus on healthcare innovations. His patent reflects his expertise in diabetes management and his dedication to improving the quality of life for diabetic patients. With a single patent to his name, Kearney has established himself as a valuable contributor to medical technology.
Collaborations
Kearney has worked alongside talented individuals such as Anas El Fathi and Ahmad Mohamad Haidar. Their collaboration has likely contributed to the development and refinement of his innovative solutions in diabetes therapy.
Conclusion
Robert Edward Kearney's work exemplifies the impact of innovation in healthcare, particularly in diabetes management. His patent serves as a testament to his dedication to improving patient outcomes through technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile